Advertisement

Cancer Talk

  • Remote Care  

    Remote Care

    After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.

    by Jon Kelvey
  • Moving Away From the Maximum Tolerated Dose  

    Moving Away From the Maximum Tolerated Dose

    The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

    by Marcus A. Banks
  • The Individual Sphere of Influence  

    The Individual Sphere of Influence

    Can discussion of health inequities lead to actionable change?

    by Marci A. Landsmann
  • A Treatment That Came Just in Time  

    A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami
Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR

Cancer Progress Report

The AACR Cancer Progress Report 2020, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.

Supporters

... ... ... ... ... ...